Hudson Bay Capital Management LP Bridge Bio Pharma, Inc. Transaction History

Hudson Bay Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $895,758 - $1.21 Million	38,946 New	38,946 $986,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $518,391 - $1.34 Million	72,300 New	72,300 $1.2 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $555,800 - $865,200	-70,000 Reduced 70.0%	30,000 $298,000
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $260,500 - $607,000	50,000 Added 100.0%	100,000 $908,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $367,000 - $858,000	50,000 New	50,000 $508,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $227,600 - $1.07 Million	-20,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $937,400 - $1.28 Million	20,000 New	20,000 $937,000
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $272,000 - $421,900	-10,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $222,200 - $356,900	10,000 New	10,000 $326,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.